|
|
Volumn 24, Issue 7, 2006, Pages 737-739
|
|
Patently absurd?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ADALIMUMAB;
ANTIBIOTIC AGENT;
ATORVASTATIN;
BORTEZOMIB;
CELECOXIB;
CONJUGATED ESTROGEN;
CYCLOOXYGENASE 2 INHIBITOR;
CYCLOSPORIN A;
DEXAMETHASONE;
DROTRECOGIN;
ESTROGEN;
ETANERCEPT;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
INFLIXIMAB;
LENALIDOMIDE;
LOSARTAN POTASSIUM;
PHOSPHOTRANSFERASE INHIBITOR;
PREDNISONE;
QUINAPRIL;
RALOXIFENE;
RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
STEROID;
SULINDAC;
TACROLIMUS;
AUTOIMMUNE DISEASE;
BIOTECHNOLOGY;
CANCER;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG MARKETING;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERTENSION;
MULTIPLE MYELOMA;
OSTEOARTHRITIS;
OSTEOPOROSIS;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
SEPSIS;
SHORT SURVEY;
TREATMENT INDICATION;
BIOTECHNOLOGY;
DRUG DESIGN;
DRUG INDUSTRY;
NF-KAPPA B;
PATENTS;
|
|
EID: 33746137747
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0706-737 Document Type: Short Survey |
|
Times cited : (3)
|
|
References (5)
|
